What is a stock summary page? Click here for an overview.
Business Description

Bumrungrad Hospital PCL
ISIN : TH0168010R13
Share Class Description:
BUGDF: Units Non-Voting Depository ReceiptCompare
Compare
Traded in other countries / regions
BH.ThailandBUHPF.USABZ7A.Germany IPO Date
2008-02-13Description
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 86.87 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 1102.35 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 19.8 | |||||
Beneish M-Score | -2.06 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.3 | |||||
3-Year EBITDA Growth Rate | 56.3 | |||||
3-Year EPS without NRI Growth Rate | 83.4 | |||||
3-Year FCF Growth Rate | 41.6 | |||||
3-Year Book Growth Rate | 16.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 2.14 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.83 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 99.99 | |||||
14-Day RSI | 99.86 | |||||
12-1 Month Momentum % | 29.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.37 | |||||
Quick Ratio | 4.28 | |||||
Cash Ratio | 3.17 | |||||
Days Inventory | 9.71 | |||||
Days Sales Outstanding | 55.41 | |||||
Days Payable | 29.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 17.2 | |||||
Shareholder Yield % | 2.93 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.38 | |||||
Operating Margin % | 35.73 | |||||
Net Margin % | 30.23 | |||||
FCF Margin % | 28.49 | |||||
ROE % | 30.39 | |||||
ROA % | 25.29 | |||||
ROIC % | 48.3 | |||||
3-Year ROIIC % | 162.53 | |||||
ROC (Joel Greenblatt) % | 71.26 | |||||
ROCE % | 35.12 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.69 | |||||
Forward PE Ratio | 28.57 | |||||
PE Ratio without NRI | 18.65 | |||||
Shiller PE Ratio | 31.13 | |||||
Price-to-Owner-Earnings | 17.95 | |||||
PEG Ratio | 0.76 | |||||
PS Ratio | 5.65 | |||||
PB Ratio | 4.84 | |||||
Price-to-Tangible-Book | 4.98 | |||||
Price-to-Free-Cash-Flow | 19.77 | |||||
Price-to-Operating-Cash-Flow | 16.75 | |||||
EV-to-EBIT | 12.86 | |||||
EV-to-Forward-EBIT | 15.58 | |||||
EV-to-EBITDA | 11.55 | |||||
EV-to-Forward-EBITDA | 14.02 | |||||
EV-to-Revenue | 4.72 | |||||
EV-to-Forward-Revenue | 5.63 | |||||
EV-to-FCF | 16.53 | |||||
Price-to-GF-Value | 0.62 | |||||
Price-to-Projected-FCF | 1.75 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.75 | |||||
Price-to-Graham-Number | 2.03 | |||||
Price-to-Net-Current-Asset-Value | 11.47 | |||||
Price-to-Net-Cash | 19.3 | |||||
Earnings Yield (Greenblatt) % | 7.78 | |||||
FCF Yield % | 5.52 | |||||
Forward Rate of Return (Yacktman) % | 22.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BUGDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bumrungrad Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 735.714 | ||
EPS (TTM) ($) | 0.257 | ||
Beta | -0.29 | ||
3-Year Sharpe Ratio | 0.75 | ||
3-Year Sortino Ratio | 1.82 | ||
Volatility % | 18.92 | ||
14-Day RSI | 99.86 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 7.9135 | ||
12-1 Month Momentum % | 29.31 | ||
52-Week Range ($) | 6.12 - 7.9135 | ||
Shares Outstanding (Mil) | 794.96 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bumrungrad Hospital PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bumrungrad Hospital PCL Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Bumrungrad Hospital PCL Frequently Asked Questions
What is Bumrungrad Hospital PCL(BUGDF)'s stock price today?
The current price of BUGDF is $7.91. The 52 week high of BUGDF is $7.91 and 52 week low is $6.12.
When is next earnings date of Bumrungrad Hospital PCL(BUGDF)?
The next earnings date of Bumrungrad Hospital PCL(BUGDF) is .
Does Bumrungrad Hospital PCL(BUGDF) pay dividends? If so, how much?
Bumrungrad Hospital PCL(BUGDF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |